These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32171919)

  • 1. Usefulness of vasculitis biomarkers in the era of the personalized medicine.
    Csernok E; Hellmich B
    Autoimmun Rev; 2020 May; 19(5):102514. PubMed ID: 32171919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
    Ozen S; Batu ED
    Front Immunol; 2018; 9():1892. PubMed ID: 30154798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculitis update: pathogenesis and biomarkers.
    Brogan P; Eleftheriou D
    Pediatr Nephrol; 2018 Feb; 33(2):187-198. PubMed ID: 28785984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current State of Precision Medicine in Primary Systemic Vasculitides.
    Demirkaya E; Arici ZS; Romano M; Berard RA; Aksentijevich I
    Front Immunol; 2019; 10():2813. PubMed ID: 31921111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and risk of primary systemic vasculitis: a propensity score matching analysis.
    Khabbazi A; Alinejati B; Hajialilo M; Ghojazadeh M; Malek Mahdavi A
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):243-250. PubMed ID: 32476959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis.
    Villa-Forte A; ;
    Curr Opin Rheumatol; 2010 Jan; 22(1):49-53. PubMed ID: 19823089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?
    Watts RA
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():21-27. PubMed ID: 29707909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis.
    Sawalha AH; Dozmorov MG
    J Autoimmun; 2016 Feb; 67():76-81. PubMed ID: 26492816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year in review 2020: vasculitis.
    Felicetti M; Treppo E; Posarelli C; Ferro F; Bond M; Monti S; Elefante E; Trentin F; Delvino P; Talarico R; Baldini C; Quartuccio L
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):3-14. PubMed ID: 32359039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculitis: report from Mexico.
    Flores-Suárez LF
    Clin Exp Nephrol; 2013 Oct; 17(5):715-717. PubMed ID: 23229651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modern therapy of systemic vasculitides: perspectives and challenges.
    Novikov PI; Zykova AS; Moiseev SV
    Ter Arkh; 2018 Feb; 90(1):76-85. PubMed ID: 30701763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy Outcomes in Systemic Vasculitides.
    Ross C; D'Souza R; Pagnoux C
    Curr Rheumatol Rep; 2020 Aug; 22(10):63. PubMed ID: 32845412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
    Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year in review 2019: vasculitis.
    Monti S; Bond M; Felicetti M; Cavallaro E; Posarelli C; Elefante E; Ferro F; Talarico R; Quartuccio L; Baldini C
    Clin Exp Rheumatol; 2019; 37 Suppl 117(2):3-19. PubMed ID: 31162034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concept and epidemiology of systemic vasculitides.
    Katsuyama T; Sada KE; Makino H
    Allergol Int; 2014 Dec; 63(4):505-13. PubMed ID: 25339434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent pathogenetic advances in ANCA-associated vasculitis.
    Pendergraft WF; Nachman PH
    Presse Med; 2015 Jun; 44(6 Pt 2):e223-9. PubMed ID: 26033562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the role of epigenetics in systemic vasculitis.
    Coit P; Direskeneli H; Sawalha AH
    Curr Opin Rheumatol; 2018 Jan; 30(1):4-15. PubMed ID: 28957963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic vasculitis: one year in review 2024.
    Treppo E; Monti S; Delvino P; Marvisi C; Ricordi C; La Rocca G; Moretti M; Italiano N; Di Cianni F; Ferro F; Muratore F; Baldini C; Talarico R; Quartuccio L; Salvarani C
    Clin Exp Rheumatol; 2024 Apr; 42(4):771-781. PubMed ID: 38683204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New features of systemic vasculitides.
    Yamaguchi M; Izuhara K
    Allergol Int; 2014 Dec; 63(4):503-4. PubMed ID: 25574557
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin involvement in cutaneous and systemic vasculitis.
    Marzano AV; Vezzoli P; Berti E
    Autoimmun Rev; 2013 Feb; 12(4):467-76. PubMed ID: 22959234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.